CANY
FULC icon

Caxton Associates (New York)’s Fulcrum Therapeutics FULC Stock Holding History

Caxton Associates (New York)’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-18,875
Closed -$117K – 565
2024
Q2 		$117K Buy
+18,875
New +$117K ﹤0.01% 457